A phase 3 trial comparing ixekizumab with placebo and etanercept for moderate-to-severe plaque psoriasis: Results from the 12 week induction period of UNCOVER-2

Authors
Category Primary study
JournalJournal of Investigative Dermatology
Year 2015
This article has no abstract
Epistemonikos ID: c1f567adab0e86be5f4de27621161902c7440357
First added on: Feb 07, 2025